Case Law: What do the Courts Say? Both Federal Circuit and lower courts have handed out a mixed bag of cases in biotech/pharma. I will detail a few important ones…
USPTO TRIES TO PLUG IN THE VOID The U.S. Supreme Court has had several opportunities to provide clarity but refused to revisit the patent eligibility of diagnostic methods. For example,…
As I explain in my previous blogs, the U.S. patent law relevant to subject matter eligibility is currently in a state of flux and baffling. The lower court’s recent decisions,…
This blog aims to walk you through all the steps involved in drafting and submitting a provisional patent application to the USPTO. This assumption is that your invention is either…